Teamlasvegas Friday, 12/28/07 12:52:56 PM Re: None Post # of 39 Shares of Immtech Pharmaceuticals Inc. (IMM) were on the rebound, up 10% to $2.38. The stock lost almost half its value earlier in the week after Immtech said it was temporarily halting Phase III testing of its drug parfuramidine over safety concerns. The company has been testing the drug against a certain type of pneumonia that commonly strikes AIDS patients. Immtech has been co-developing parfuramidine with Par Pharmaceutical Cos. (PRX). Shares of Par were down almost 3% to $23.72. "Your Vegas Is Showing" I've been to Hollywood I've been to Redwood I crossed the ocean for a heart of gold I've been in my mind, it's such a fine line Later, The Team.